
The concept of innovative drugs surged and then fell back, with Hob Biotech dropping over 10%
The innovative drug concept surged and then fell during the session, with Hob Biotech dropping over 10%, RemeGen, ApicHope, Shouyao Holdings, Hotgen, and Norland all falling over 5%

